Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Consumerism

Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Principal, Health & Life Sciences, Oliver Wyman

Purposeful collaboration will help more people understand how their daily decisions dictate their health.

Principal, Oliver Wyman

Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?

Partner, Health & Life Sciences, Oliver Wyman

Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.

Principal, Oliver Wyman Actuarial Consulting
Global Head, Health Services, Oliver Wyman
Principal, Oliver Wyman

Insights in your inbox

Subscribe

The next global trend in medicine could be among the many traditional remedies in Indonesia, Vietnam, and China.

Engagement Manager, Health & Life Sciences, Oliver Wyman

A discussion on how mega mergers affect consumers and how consolidation is driving the new future of healthcare.

Health and wellness is shaping consumerism’s future. As potentially industry-shaking partnerships evolve, who’s best positioned to conquer the market?

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, Oliver Wyman

Some of our 2017 healthcare predictions on value-based care, consumers, mergers, startups, and pharma came true, while others were less predictable.

Principal, Oliver Wyman

Insights in your inbox

Subscribe